C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2011
10/13/2011	US20110251251 Polymorph ii of an antifungal compound
10/13/2011	US20110251242 Photostabilization of resveratrol with alkoxycrylene compounds
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251182 Agents and methods for treating ischemic and other diseases
10/13/2011	US20110251181 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251174 2,4-diamino-pyrimidines as aurora inhibitors
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251069 Isoxazole derivatives for use as plant growth regulators
10/13/2011	US20110250254 Antimicrobial compositions and uses
10/13/2011	US20110248224 Thermochromic indicator materials with controlled reversibility
10/13/2011	CA2829790A1 Multisubstituted aromatic compounds as inhibitors of thrombin
10/12/2011	EP2374804A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2373630A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
10/12/2011	EP1761522B1 Compounds and methods for treating dyslipidemia
10/12/2011	CN1914177B Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
10/12/2011	CN102216295A 8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
10/12/2011	CN102216283A Quinazoline derivatives as NK3 receptor antagonists
10/12/2011	CN102216277A Novel compounds as cannabinoid receptor ligands
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102212058A Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN101421252B 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/12/2011	CN101296909B Pyrazine derivatives and use as pI3K inhibitors
10/12/2011	CN101258134B 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
10/11/2011	US8034961 Reduction of 4-aryl-4-ketobutanoic acid derivatives utilizing ruthenium containing catalysts
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	CA2655395C Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2504907C Indoles useful in the treatment of androgen-receptor related diseases
10/11/2011	CA2471436C Non-sedating barbituric acid derivatives
10/10/2011	CA2793975A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011121629A1 Indolic derivatives and use thereof in medical field
10/06/2011	WO2011121555A1 Antibacterial isoquinolin-3-ylurea derivatives
10/06/2011	WO2011121418A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	WO2011121308A1 New polymorph
10/06/2011	WO2011080254A3 Fungicide hydroximoyl-heterocycles derivatives
10/06/2011	WO2011045415A3 Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
10/06/2011	WO2011012618A3 Processes relating to the alkylation of pyrazoles
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245264 Modulators of G Protein-Coupled Receptor 88
10/06/2011	US20110245262 Compounds for treating proliferative disorders
10/06/2011	US20110245260 Analogs of dehydrophenylahistins and their therapeutic use
10/06/2011	US20110245257 Heterocyclic compounds and their uses
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245249 Heterocyclically Substituted Anilinopyrimidines
10/06/2011	US20110245231 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
10/06/2011	US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110243850 Probe for a biological specimen and labelling method and screening method using the probe
10/06/2011	US20110240980 n-Type Doped Organic Materials and Methods Therefor
10/06/2011	US20110239903 Modified pigments and methods for making and using the same
10/06/2011	CA2795009A1 Aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	CA2793897A1 Heterocyclic compounds and their uses
10/05/2011	EP2371829A1 Method for producing benzo-trithiophene or benzo-triselenophene derivatives
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370425A2 Fused imidazole derivatives as trpv3 antagonist
10/05/2011	EP2370422A1 Thiochromene derivatives as hip hydroxylase inhibitors
10/05/2011	EP2370413A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2370111A1 Probe for a biological specimen and labelling method and screening method using the probe
10/05/2011	EP2369935A1 Stable insecticide compositions and methods for producing same
10/05/2011	EP2369921A1 Stable sulfoximine-insecticide compositions
10/05/2011	EP1966151B1 Polycyclic indazole derivatives that are erk inhibitors
10/05/2011	EP1960370B1 Pyridiazinone derivatives for tumour treatment
10/05/2011	EP1958948B1 Pyridazine compound and use thereof
10/05/2011	EP1899329B1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors
10/05/2011	EP1411052B1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209717A Compounds for the treatment of hepatitis c
10/05/2011	CN102209714A Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
10/05/2011	CN102206180A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
10/05/2011	CN102206172A Substituted diaryl compound and preparation method and antiviral application thereof
10/05/2011	CN101538288B Monomer for organic electro-phosphorescent polymer
10/05/2011	CN101531686B Monomer for organic electrophosphorescent polymer
10/05/2011	CN101351446B Novel fused pyrrole derivatives
10/05/2011	CN101300229B 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
10/05/2011	CN101031558B HIV inhibiting 5-heterocyclyl pyrimidines
10/04/2011	US8032873 Computer program code size partitioning system for multiple memory multi-processing systems
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents
10/04/2011	US8030339 Imidazole derivatives for the treatment of anxiety and related diseases
10/04/2011	US8030336 Nicotinamide-based kinase inhibitors
10/04/2011	US8030330 Benzothiophenes, formulations containing same, and methods
10/04/2011	US8030322 Spirocompounds useful as modulators for dopamine D3 receptors
10/04/2011	US8030309 Viral polymerase inhibitors
10/04/2011	CA2507501C 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/2011
09/29/2011	WO2011119853A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011117804A1 Pyridazine compounds for controlling invertebrate pests
09/29/2011	WO2011117382A1 Pyridyltriazoles

1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 523